These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7839822)

  • 1. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.
    Shetty VP; Uplekar MW; Antia NH
    Acta Neuropathol; 1994; 88(4):300-6. PubMed ID: 7839822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique.
    Mshana RN; Humber DP; Harboe M; Belehu A
    Clin Immunol Immunopathol; 1983 Dec; 29(3):359-68. PubMed ID: 6416726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
    Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
    Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy.
    Barros U; Shetty VP; Antia NH
    Acta Neuropathol; 1987; 73(4):387-92. PubMed ID: 2441563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of nerve destruction in tuberculoid-borderline leprosy. An electron-microscopic study.
    Job CK
    J Neurol Sci; 1973 Sep; 20(1):25-38. PubMed ID: 4582968
    [No Abstract]   [Full Text] [Related]  

  • 6. The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions.
    Lockwood DN; Colston MJ; Khanolkar-Young SR
    Am J Trop Med Hyg; 2002 Apr; 66(4):409-15. PubMed ID: 12164297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
    Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
    Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
    Shetty VP; Suchitra K; Uplekar MW; Antia NH
    Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
    Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
    Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the neural predilection of Mycobacterium leprae in leprosy.
    Stoner GL
    Lancet; 1979 Nov; 2(8150):994-6. PubMed ID: 91779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients.
    Barros U; Ladiwala U; Birdi TJ; Antia NH
    Br J Exp Pathol; 1987 Oct; 68(5):733-41. PubMed ID: 3318906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of M. leprae-specific antigens with dot-ELISA in urine and nasal samples from leprosy patients.
    Singh NB; Choudhary A; Bhatnagar S
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):398-404. PubMed ID: 1890363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.
    Spierings E; de Boer T; Wieles B; Adams LB; Marani E; Ottenhoff TH
    J Immunol; 2001 May; 166(10):5883-8. PubMed ID: 11342602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical, immunological, and histological study of neuritic leprosy patients.
    Kaur G; Girdhar BK; Girdhar A; Malaviya GN; Mukherjee A; Sengupta U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):385-91. PubMed ID: 1890361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
    Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
    Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.
    Verhagen C; Faber W; Klatser P; Buffing A; Naafs B; Das P
    Am J Pathol; 1999 Jun; 154(6):1793-804. PubMed ID: 10362804
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.